RGT
Click for more information
3.51% 29.5¢ argent biopharma limited

Contracts and Revenue Questions, page-59

  1. pnh88
    327 Posts.
    lightbulb Created with Sketch. 94
    clock Created with Sketch.
    26/06/19
    22:14
    Post #: 39256606
    OK pfm I'm with you. Whilst I don't think you will get any answers directly to your questions separately, I also don't think we will get any clarity to the questions you pose in the quarterly either. None of what you have asked is at all emotional fixated or frantic. Good luck with getting direct answers, they are exactly what I and many others would like answers to also.
    MXC Price at posting: 5.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
RHK Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
29.5¢ 		Change
0.010(3.51%) 		Mkt cap ! $14.27M
Open High Low Value Volume
29.5¢ 29.5¢ 29.5¢ $1.476K 5.002K

Buyers (Bids)

No. Vol. Price($)
1 71 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 208 3
View Market Depth
Last trade - 10.07am 30/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.